Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 3
1950 2
1951 2
1952 2
1953 3
1954 3
1955 10
1956 3
1957 4
1960 3
1961 1
1962 2
1963 2
1964 6
1965 2
1967 4
1968 4
1970 3
1971 1
1972 2
1974 1
1977 1
1980 2
1982 1
1986 1
1987 1
1988 1
1989 4
1990 2
1991 2
1992 2
1994 2
1995 4
1996 2
1997 4
1998 3
1999 3
2000 2
2001 5
2002 4
2003 8
2004 9
2005 7
2006 4
2007 11
2008 7
2009 6
2010 10
2011 5
2012 5
2013 11
2014 5
2015 5
2016 2
2017 8
2018 5
2019 6
2020 6
2021 8
2022 8
2023 10
2024 3
2025 7
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

257 results

Results by year

Filters applied: . Clear all
Page 1
Targeting the IL34-CSF1R axis improves metastatic renal cell carcinoma therapy outcome via immune-vascular crosstalk regulation.
Emanuelli A, Souleyreau W, Chouleur T, Boeckx B, Pobiedonoscew Y, Cooley L, Derieppe MA, Martineau J, Ambrosetti D, Bernhard JC, Sawai CM, Lambrechts D, Mathivet T, Bikfalvi A. Emanuelli A, et al. Among authors: bikfalvi a. iScience. 2025 May 26;28(6):112752. doi: 10.1016/j.isci.2025.112752. eCollection 2025 Jun 20. iScience. 2025. PMID: 40538439 Free PMC article.
A strategy for multimodal integration of transcriptomics, proteomics, and radiomics data for the prediction of recurrence in patients with IDH-mutant gliomas.
Chouleur T, Etchegaray C, Villain L, Lesur A, Ferté T, Rossi M, Andrique L, Simoncini C, Giacobbi AS, Gambaretti M, Lopci E, Fernades B, Dittmar G, Bjerkvig R, Hejblum B, Thiébaut R, Saut O, Bello L, Bikfalvi A. Chouleur T, et al. Among authors: bikfalvi a. Int J Cancer. 2025 Aug 1;157(3):573-587. doi: 10.1002/ijc.35441. Epub 2025 Apr 11. Int J Cancer. 2025. PMID: 40214613 Free PMC article.
Exploiting metabolic vulnerability in glioblastoma using a brain-penetrant drug with a safe profile.
Burban A, Tessier C, Larroquette M, Guyon J, Lubiato C, Pinglaut M, Toujas M, Galvis J, Dartigues B, Georget E, Luchman HA, Weiss S, Cappellen D, Nicot N, Klink B, Nikolski M, Brisson L, Mathivet T, Bikfalvi A, Daubon T, Sharanek A. Burban A, et al. Among authors: bikfalvi a. EMBO Mol Med. 2025 Mar;17(3):469-503. doi: 10.1038/s44321-025-00195-6. Epub 2025 Feb 3. EMBO Mol Med. 2025. PMID: 39901019 Free PMC article.
257 results